Free Trial

Revolution Medicines (RVMDW) Competitors

$0.18 +0.00 (+1.93%)
(As of 12/20/2024 05:16 PM ET)

RVMDW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CEROW

Should you be buying Revolution Medicines stock or one of its competitors? The main competitors of Revolution Medicines include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and CERo Therapeutics (CEROW). These companies are all part of the "biotechnology" industry.

Revolution Medicines vs.

Revolution Medicines (NASDAQ:RVMDW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, community ranking, analyst recommendations, dividends, institutional ownership and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution Medicines$742KN/AN/AN/AN/A
180 Life SciencesN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
180 Life Sciences N/A N/A N/A

In the previous week, Revolution Medicines' average media sentiment score of 0.00 equaled 180 Life Sciences'average media sentiment score.

Company Overall Sentiment
Revolution Medicines Neutral
180 Life Sciences Neutral

Revolution Medicines and 180 Life Sciences both received 0 outperform votes by MarketBeat users.

CompanyUnderperformOutperform
Revolution MedicinesN/AN/A
180 Life SciencesN/AN/A

Summary

Revolution Medicines beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVMDW vs. The Competition

MetricRevolution MedicinesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$165.68M$5.14B$9.08B
Dividend YieldN/A3.64%5.09%4.23%
P/E RatioN/A115.5190.1317.19
Price / SalesN/A18,531.021,116.25117.05
Price / CashN/A12.8743.1037.85
Price / BookN/A8.594.784.78
Net IncomeN/A-$20.67M$120.31M$225.60M
7 Day Performance-42.51%-1.05%-1.92%-1.23%
1 Month Performance-57.66%174.77%13.65%0.46%
1 Year Performance-55.00%134.18%28.34%15.24%

Revolution Medicines Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVMDW
Revolution Medicines
N/A$0.18
+1.9%
N/A-50.7%$0.00$742,000.000.00378Gap Up
ATNFW
180 Life Sciences
N/A$0.01
flat
N/A+31.6%$0.00N/A0.007Positive News
Gap Down
SXTPW
60 Degrees Pharmaceuticals
N/A$0.02
-51.3%
N/A-56.7%$0.00$502,409.000.002Positive News
Gap Down
High Trading Volume
DRTSW
Alpha Tau Medical
N/A$0.20
-21.3%
N/A+68.4%$0.00N/A0.0080Positive News
Gap Down
WENAW
Anew Medical
N/A$0.04
-0.3%
N/AN/A$0.00N/A0.00N/AGap Down
APLMW
Apollomics
N/A$0.01
+3.1%
N/A-45.9%$0.00N/A0.0059News Coverage
Gap Up
BCTXW
BriaCell Therapeutics
N/A$0.35
-14.0%
N/A-82.3%$0.00N/A0.008
CDIOW
Cardio Diagnostics
N/A$0.12
+10.2%
N/A-34.7%$0.00$35,688.000.007Positive News
Gap Up
High Trading Volume
CTCXW
Carmell
N/A$0.05
flat
N/AN/A$0.00$32,839.000.009Positive News
Gap Down
CELUW
Celularity
N/A$0.02
flat
N/A-19.6%$0.00$48.20M0.00220Positive News
Gap Up
High Trading Volume
CEROW
CERo Therapeutics
N/A$0.02
+25.0%
N/AN/A$0.00N/A0.008Gap Down

Related Companies and Tools


This page (NASDAQ:RVMDW) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners